TrialBlood2024
A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.
John Magenau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
TrialBlood2024
John Magenau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.